Medco 2014 Annual Report Download - page 31
Download and view the complete annual report
Please find page 31 of the 2014 Medco annual report below. You can navigate through the pages in the report by either clicking on the pages listed below, or by using the keyword search tool below to find specific information within the annual report.29
Express Scripts 2014 Annual Report
Changes in drug pricing or industry pricing benchmarks could materially impact our financial performance.
Contractsintheprescriptiondrugindustry,includingourcontractswithretailpharmacynetworksandwithPBM
andspecialtypharmacyclients,generallyuse“averagewholesaleprice”or“AWP,”whichispublishedbyathirdparty,asa
benchmarktoestablishpricingforprescriptiondrugs.Intheevent(i)AWPisnolongerpublishedbythirdparties,(ii)weadopt
otherpricingbenchmarksforestablishingpriceswithintheindustryor(iii)futurechangesindrugpricessubstantiallydeviate
fromourexpectations,wecangivenoassurancetheshort-orlong-termimpactofsuchchangestoindustrypricingbenchmarks
ordrugpriceswillnothaveamaterialadverseeffectonourbusinessandresultsofoperations.
Legislationandotherregulationsaffectingdrugpricesaredescribedinmoredetailunder“PartI—Item1—
Business—GovernmentRegulationandCompliance—LegislationandRegulationAffectingDrugPrices”above.
Pending and future litigation, investigations or other proceedings could subject us to significant monetary damages or
penalties and/or require us to change our business practices, which could have a material adverse effect on our business and
results of operations.
Wearesubjecttorisksrelatingtolitigation,enforcementaction,regulatoryproceedings,governmentinquiriesand
investigationsandothersimilaractionsinconnectionwithourbusinessoperations,includingwithoutlimitationthedispensing
ofpharmaceuticalproductsbyourspecialtyandhomedeliverypharmacies,servicesrenderedinconnectionwithourdisease
managementoffering,ourpharmaceuticalservicesoperations,pharmacybenefitmanagementservicesandmergersand
acquisitionsactivity.Theseproceedingsseekunspecifiedmonetarydamagesand/orequitablerelief.Whilewebelievethese
proceedingsarewithoutmeritandintendtocontestthemvigorously,wecannotpredictwithcertaintytheoutcomeofanysuch
proceedings.Ifoneormoreoftheseproceedingshasanunfavorableoutcome,wecannotprovideanyassuranceitwouldnot
haveamaterialadverseeffectonourbusinessandresultsofoperations,includingourabilitytoattractandretainclientsasa
resultofanynegativereputationalimpactofsuchanoutcome.Further,whilecertaincostsarecoveredbyinsurance,wemay
incuruninsuredcoststhatarematerialtoourfinancialperformanceinthedefenseofsuchproceedings.
Commercialliabilityinsurancecoveragecontinuestobedifficulttoobtainforcompaniesinourbusinesssector,as
suchinsurancecancauseunexpectedvolatilityinpremiumsand/orretentionrequirementsdictatedbyinsurancecarriers.We
haveestablishedcertainself-insuranceaccrualstocoveranticipatedlosseswithinourretainedliabilityforpreviouslyreported
claimsandthecosttodefendtheseclaims.However,therecanbenoassurancesuchaccrualswillcoveractuallossesorthat
general,professional,managedcareerrorsandomissions,and/orotherliabilityinsurancecoveragewillbereasonablyavailable
inthefutureorsuchinsurancecoverage,togetherwithourself-insuranceaccruals,willbeadequatetocoverfutureclaims.A
claim,orclaims,inexcessofourinsurancecoveragecouldhaveamaterialadverseeffectonourbusinessandresultsof
operations.
We face significant competition in attracting and retaining talented employees. Further, managing succession and retention for
our Chief Executive Officer and other key executives is critical to our success, and our failure to do so could have an adverse
impact on our future performance.
Ourabilitytoattractandretainaqualifiedandexperiencedworkforceisessentialtomeetcurrentandfuturegoals
andobjectivesandthereisnoguaranteewewillbeabletoattractandretainsuchemployeesorthatcompetitionamong
potentialemployerswillnotresultinincreasedsalariesorotherbenefits.Aninabilitytoretainexistingemployeesorattract
additionalemployees,oranunexpectedlossofleadership,couldhaveamaterialadverseeffectonourbusinessandresultsof
operations.
Inaddition,ourfailuretoadequatelyplanforsuccessionofourChiefExecutiveOfficer,seniormanagementand
otherkeyemployeesorthefailureofkeyemployeestosuccessfullytransitionintonewrolescouldhaveamaterialadverse
effectonourbusinessandresultsofoperations.Whilewehavesuccessionplansinplaceandemploymentarrangementswith
certainkeyexecutives,thesedonotguaranteetheservicesoftheseexecutiveswillcontinuetobeavailabletous.
25
Item 1B — Unresolved Staff Comments
TherearenounresolvedwrittencommentsreceivedfromtheSECStaff180daysormorebeforetheendofour
fiscalyearrelatingtoourperiodicorcurrentreportsundertheSecuritiesExchangeActof1934.